September 2, 2020
Janssen Pharmaceutical, the Japan pharma arm of Johnson & Johnson, said on September 1 that it has commenced a clinical trial in Japan for its novel coronavirus vaccine candidate Ad26.COV2.S. The trial is designed to gauge the safety, reactogenicity, and...read more